APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemostatic Agents

Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.

Selected research

Market Structure

Global Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

25 December 2025191 pages

Choose your research edition.

Industry ResearchHemostatic Agents Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemostatic Agents Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemostatic Agents Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemostatic Agents Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.

The world's leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LiLifeSciences, B Braun Melsungen and Gelita Medical.

This report provides an overview of the global Hemostatic Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Hemostatic Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemostatic Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemostatic Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemostatic Agents Segment by Company

Ethicon

Pfizer

Baxter International

C. R. Bard

The Medicines Company

Anika Therapeutics

Advanced Medical Solutions

Integra LifeSciences

B Braun Melsungen

Gelita Medical

Equimedical

Vascular Solutions

Marine Polymer Technologies

Z-Medica

CryoLife

BioCer Entwicklungs

Biom’Up SAS

Hemostatic Agents Segment by Type

Gelation Sponge

Oxidized Regenerated Cellulose Based Hemostats

Others

Hemostatic Agents Segment by Application

Hospitals

Surgical Centers

Nursing Homes

Hemostatic Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemostatic Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hemostatic Agents Industry Trends Table 2. Hemostatic Agents Industry Drivers Table 3. Hemostatic Agents Industry Opportunities and Challenges Table 4. Hemostatic Agents Industry Restraints Table 5. Global Hemostatic Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hemostatic Agents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hemostatic Agents Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hemostatic Agents Sales Market Share by Manufacturers Table 9. Global Hemostatic Agents Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Hemostatic Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hemostatic Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hemostatic Agents Manufacturers, Product Type & Application Table 13. Global Hemostatic Agents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemostatic Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Gelation Sponge Table 17. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats Table 18. Major Manufacturers of Others Table 19. Global Hemostatic Agents Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 21. Global Hemostatic Agents Sales by Type (2027-2032) & (K Units) Table 22. Global Hemostatic Agents Sales Market Share by Type (2021-2026) Table 23. Global Hemostatic Agents Sales Market Share by Type (2027-2032) Table 24. Global Hemostatic Agents Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Hemostatic Agents Revenue by Type (2021-2026) & (K Units) Table 26. Global Hemostatic Agents Revenue by Type (2027-2032) & (K Units) Table 27. Global Hemostatic Agents Revenue Market Share by Type (2021-2026) Table 28. Global Hemostatic Agents Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Surgical Centers Table 31. Major Manufacturers of Nursing Homes Table 32. Global Hemostatic Agents Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 34. Global Hemostatic Agents Sales by Application (2027-2032) & (K Units) Table 35. Global Hemostatic Agents Sales Market Share by Application (2021-2026) Table 36. Global Hemostatic Agents Sales Market Share by Application (2027-2032) Table 37. Global Hemostatic Agents Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Hemostatic Agents Revenue by Application (2021-2026) & (K Units) Table 39. Global Hemostatic Agents Revenue by Application (2027-2032) & (K Units) Table 40. Global Hemostatic Agents Revenue Market Share by Application (2021-2026) Table 41. Global Hemostatic Agents Revenue Market Share by Application (2027-2032) Table 42. Global Hemostatic Agents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Hemostatic Agents Sales by Region (2021-2026) & (K Units) Table 44. Global Hemostatic Agents Sales Market Share by Region (2021-2026) Table 45. Global Hemostatic Agents Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Hemostatic Agents Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 49. North America Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 50. Europe Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 52. Europe Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 59. Global Hemostatic Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Hemostatic Agents Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Hemostatic Agents Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Hemostatic Agents Revenue Market Share by Region (2021-2026) Table 63. Global Hemostatic Agents Revenue Market Share by Region (2027-2032) Table 64. Ethicon Company Information Table 65. Ethicon Business Overview Table 66. Ethicon Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Ethicon Hemostatic Agents Product Portfolio Table 68. Ethicon Recent Development Table 69. Pfizer Company Information Table 70. Pfizer Business Overview Table 71. Pfizer Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Pfizer Hemostatic Agents Product Portfolio Table 73. Pfizer Recent Development Table 74. Baxter International Company Information Table 75. Baxter International Business Overview Table 76. Baxter International Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Baxter International Hemostatic Agents Product Portfolio Table 78. Baxter International Recent Development Table 79. C. R. Bard Company Information Table 80. C. R. Bard Business Overview Table 81. C. R. Bard Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. C. R. Bard Hemostatic Agents Product Portfolio Table 83. C. R. Bard Recent Development Table 84. The Medicines Company Company Information Table 85. The Medicines Company Business Overview Table 86. The Medicines Company Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. The Medicines Company Hemostatic Agents Product Portfolio Table 88. The Medicines Company Recent Development Table 89. Anika Therapeutics Company Information Table 90. Anika Therapeutics Business Overview Table 91. Anika Therapeutics Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Anika Therapeutics Hemostatic Agents Product Portfolio Table 93. Anika Therapeutics Recent Development Table 94. Advanced Medical Solutions Company Information Table 95. Advanced Medical Solutions Business Overview Table 96. Advanced Medical Solutions Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Advanced Medical Solutions Hemostatic Agents Product Portfolio Table 98. Advanced Medical Solutions Recent Development Table 99. Integra LifeSciences Company Information Table 100. Integra LifeSciences Business Overview Table 101. Integra LifeSciences Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Integra LifeSciences Hemostatic Agents Product Portfolio Table 103. Integra LifeSciences Recent Development Table 104. B Braun Melsungen Company Information Table 105. B Braun Melsungen Business Overview Table 106. B Braun Melsungen Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. B Braun Melsungen Hemostatic Agents Product Portfolio Table 108. B Braun Melsungen Recent Development Table 109. Gelita Medical Company Information Table 110. Gelita Medical Business Overview Table 111. Gelita Medical Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Gelita Medical Hemostatic Agents Product Portfolio Table 113. Gelita Medical Recent Development Table 114. Equimedical Company Information Table 115. Equimedical Business Overview Table 116. Equimedical Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Equimedical Hemostatic Agents Product Portfolio Table 118. Equimedical Recent Development Table 119. Vascular Solutions Company Information Table 120. Vascular Solutions Business Overview Table 121. Vascular Solutions Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Vascular Solutions Hemostatic Agents Product Portfolio Table 123. Vascular Solutions Recent Development Table 124. Marine Polymer Technologies Company Information Table 125. Marine Polymer Technologies Business Overview Table 126. Marine Polymer Technologies Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Marine Polymer Technologies Hemostatic Agents Product Portfolio Table 128. Marine Polymer Technologies Recent Development Table 129. Z-Medica Company Information Table 130. Z-Medica Business Overview Table 131. Z-Medica Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Z-Medica Hemostatic Agents Product Portfolio Table 133. Z-Medica Recent Development Table 134. CryoLife Company Information Table 135. CryoLife Business Overview Table 136. CryoLife Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. CryoLife Hemostatic Agents Product Portfolio Table 138. CryoLife Recent Development Table 139. BioCer Entwicklungs Company Information Table 140. BioCer Entwicklungs Business Overview Table 141. BioCer Entwicklungs Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. BioCer Entwicklungs Hemostatic Agents Product Portfolio Table 143. BioCer Entwicklungs Recent Development Table 144. Biom’Up SAS Company Information Table 145. Biom’Up SAS Business Overview Table 146. Biom’Up SAS Hemostatic Agents Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Biom’Up SAS Hemostatic Agents Product Portfolio Table 148. Biom’Up SAS Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Hemostatic Agents Distributors List Table 152. Hemostatic Agents Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Hemostatic Agents Product Image Figure 2. Global Hemostatic Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemostatic Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemostatic Agents Sales (2021-2032) & (K Units) Figure 5. Global Hemostatic Agents Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hemostatic Agents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Gelation Sponge Image Figure 9. Oxidized Regenerated Cellulose Based Hemostats Image Figure 10. Others Image Figure 11. Global Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Hemostatic Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Hemostatic Agents Sales Market Share by Type (2021-2032) Figure 14. Global Hemostatic Agents Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Hemostatic Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Hemostatic Agents Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Surgical Centers Image Figure 19. Nursing Homes Image Figure 20. Global Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Hemostatic Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Hemostatic Agents Sales Market Share by Application (2021-2032) Figure 23. Global Hemostatic Agents Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Hemostatic Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Hemostatic Agents Revenue Market Share by Application (2021-2032) Figure 26. North America Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 28. U.S. Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 33. Germany Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 40. China Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 48. Brazil Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Hemostatic Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Hemostatic Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 59. North America Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 61. Europe Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Hemostatic Agents Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Hemostatic Agents Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Gelation Sponge
  • Oxidized Regenerated Cellulose Based Hemostats
  • Others
Applications
  • Hospitals
  • Surgical Centers
  • Nursing Homes
Companies covered
  • Ethicon
  • Pfizer
  • Baxter International
  • C. R. Bard
  • The Medicines Company
  • Anika Therapeutics
  • Advanced Medical Solutions
  • Integra LifeSciences
  • B Braun Melsungen
  • Gelita Medical
  • Equimedical
  • Vascular Solutions
  • Marine Polymer Technologies
  • Z-Medica
  • CryoLife
  • BioCer Entwicklungs
  • Biom’Up SAS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hemostatic Agents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hemostatic Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hemostatic Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hemostatic Agents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hemostatic Agents Market Dynamics
  1. 2.1 Hemostatic Agents Industry Trends
  2. 2.2 Hemostatic Agents Industry Drivers
  3. 2.3 Hemostatic Agents Industry Opportunities and Challenges
  4. 2.4 Hemostatic Agents Industry Restraints
3 Hemostatic Agents Market by Manufacturers
  1. 3.1 Global Hemostatic Agents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hemostatic Agents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hemostatic Agents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hemostatic Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemostatic Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hemostatic Agents Manufacturers, Product Type & Application
  7. 3.7 Global Hemostatic Agents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemostatic Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemostatic Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemostatic Agents Tier 1, Tier 2, and Tier 3
4 Hemostatic Agents Market by Type
  1. 4.1 Hemostatic Agents Type Introduction
  2. 4.1.1 Gelation Sponge
  3. 4.1.2 Oxidized Regenerated Cellulose Based Hemostats
  4. 4.1.3 Others
  5. 4.2 Global Hemostatic Agents Sales by Type
  6. 4.2.1 Global Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Hemostatic Agents Sales by Type (2021-2032)
  8. 4.2.3 Global Hemostatic Agents Sales Market Share by Type (2021-2032)
  9. 4.3 Global Hemostatic Agents Revenue by Type
  10. 4.3.1 Global Hemostatic Agents Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Hemostatic Agents Revenue by Type (2021-2032)
  12. 4.3.3 Global Hemostatic Agents Revenue Market Share by Type (2021-2032)
5 Hemostatic Agents Market by Application
  1. 5.1 Hemostatic Agents Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Surgical Centers
  4. 5.1.3 Nursing Homes
  5. 5.2 Global Hemostatic Agents Sales by Application
  6. 5.2.1 Global Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hemostatic Agents Sales by Application (2021-2032)
  8. 5.2.3 Global Hemostatic Agents Sales Market Share by Application (2021-2032)
  9. 5.3 Global Hemostatic Agents Revenue by Application
  10. 5.3.1 Global Hemostatic Agents Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hemostatic Agents Revenue by Application (2021-2032)
  12. 5.3.3 Global Hemostatic Agents Revenue Market Share by Application (2021-2032)
6 Global Hemostatic Agents Sales by Region
  1. 6.1 Global Hemostatic Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemostatic Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Hemostatic Agents Sales by Region (2021-2026)
  4. 6.2.2 Global Hemostatic Agents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hemostatic Agents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hemostatic Agents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hemostatic Agents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hemostatic Agents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hemostatic Agents Revenue by Region
  1. 7.1 Global Hemostatic Agents Revenue by Region
  2. 7.1.1 Global Hemostatic Agents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hemostatic Agents Revenue by Region (2021-2026)
  4. 7.1.3 Global Hemostatic Agents Revenue by Region (2027-2032)
  5. 7.1.4 Global Hemostatic Agents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hemostatic Agents Revenue (2021-2032)
  8. 7.2.2 North America Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hemostatic Agents Revenue (2021-2032)
  11. 7.3.2 Europe Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hemostatic Agents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hemostatic Agents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ethicon
  2. 8.1.1 Ethicon Company Information
  3. 8.1.2 Ethicon Business Overview
  4. 8.1.3 Ethicon Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ethicon Hemostatic Agents Product Portfolio
  6. 8.1.5 Ethicon Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Hemostatic Agents Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Baxter International
  14. 8.3.1 Baxter International Company Information
  15. 8.3.2 Baxter International Business Overview
  16. 8.3.3 Baxter International Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Baxter International Hemostatic Agents Product Portfolio
  18. 8.3.5 Baxter International Recent Developments
  19. 8.4 C. R. Bard
  20. 8.4.1 C. R. Bard Company Information
  21. 8.4.2 C. R. Bard Business Overview
  22. 8.4.3 C. R. Bard Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 C. R. Bard Hemostatic Agents Product Portfolio
  24. 8.4.5 C. R. Bard Recent Developments
  25. 8.5 The Medicines Company
  26. 8.5.1 The Medicines Company Company Information
  27. 8.5.2 The Medicines Company Business Overview
  28. 8.5.3 The Medicines Company Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 The Medicines Company Hemostatic Agents Product Portfolio
  30. 8.5.5 The Medicines Company Recent Developments
  31. 8.6 Anika Therapeutics
  32. 8.6.1 Anika Therapeutics Company Information
  33. 8.6.2 Anika Therapeutics Business Overview
  34. 8.6.3 Anika Therapeutics Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Anika Therapeutics Hemostatic Agents Product Portfolio
  36. 8.6.5 Anika Therapeutics Recent Developments
  37. 8.7 Advanced Medical Solutions
  38. 8.7.1 Advanced Medical Solutions Company Information
  39. 8.7.2 Advanced Medical Solutions Business Overview
  40. 8.7.3 Advanced Medical Solutions Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Advanced Medical Solutions Hemostatic Agents Product Portfolio
  42. 8.7.5 Advanced Medical Solutions Recent Developments
  43. 8.8 Integra LifeSciences
  44. 8.8.1 Integra LifeSciences Company Information
  45. 8.8.2 Integra LifeSciences Business Overview
  46. 8.8.3 Integra LifeSciences Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Integra LifeSciences Hemostatic Agents Product Portfolio
  48. 8.8.5 Integra LifeSciences Recent Developments
  49. 8.9 B Braun Melsungen
  50. 8.9.1 B Braun Melsungen Company Information
  51. 8.9.2 B Braun Melsungen Business Overview
  52. 8.9.3 B Braun Melsungen Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 B Braun Melsungen Hemostatic Agents Product Portfolio
  54. 8.9.5 B Braun Melsungen Recent Developments
  55. 8.10 Gelita Medical
  56. 8.10.1 Gelita Medical Company Information
  57. 8.10.2 Gelita Medical Business Overview
  58. 8.10.3 Gelita Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Gelita Medical Hemostatic Agents Product Portfolio
  60. 8.10.5 Gelita Medical Recent Developments
  61. 8.11 Equimedical
  62. 8.11.1 Equimedical Company Information
  63. 8.11.2 Equimedical Business Overview
  64. 8.11.3 Equimedical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Equimedical Hemostatic Agents Product Portfolio
  66. 8.11.5 Equimedical Recent Developments
  67. 8.12 Vascular Solutions
  68. 8.12.1 Vascular Solutions Company Information
  69. 8.12.2 Vascular Solutions Business Overview
  70. 8.12.3 Vascular Solutions Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Vascular Solutions Hemostatic Agents Product Portfolio
  72. 8.12.5 Vascular Solutions Recent Developments
  73. 8.13 Marine Polymer Technologies
  74. 8.13.1 Marine Polymer Technologies Company Information
  75. 8.13.2 Marine Polymer Technologies Business Overview
  76. 8.13.3 Marine Polymer Technologies Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Marine Polymer Technologies Hemostatic Agents Product Portfolio
  78. 8.13.5 Marine Polymer Technologies Recent Developments
  79. 8.14 Z-Medica
  80. 8.14.1 Z-Medica Company Information
  81. 8.14.2 Z-Medica Business Overview
  82. 8.14.3 Z-Medica Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Z-Medica Hemostatic Agents Product Portfolio
  84. 8.14.5 Z-Medica Recent Developments
  85. 8.15 CryoLife
  86. 8.15.1 CryoLife Company Information
  87. 8.15.2 CryoLife Business Overview
  88. 8.15.3 CryoLife Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CryoLife Hemostatic Agents Product Portfolio
  90. 8.15.5 CryoLife Recent Developments
  91. 8.16 BioCer Entwicklungs
  92. 8.16.1 BioCer Entwicklungs Company Information
  93. 8.16.2 BioCer Entwicklungs Business Overview
  94. 8.16.3 BioCer Entwicklungs Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BioCer Entwicklungs Hemostatic Agents Product Portfolio
  96. 8.16.5 BioCer Entwicklungs Recent Developments
  97. 8.17 Biom’Up SAS
  98. 8.17.1 Biom’Up SAS Company Information
  99. 8.17.2 Biom’Up SAS Business Overview
  100. 8.17.3 Biom’Up SAS Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Biom’Up SAS Hemostatic Agents Product Portfolio
  102. 8.17.5 Biom’Up SAS Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemostatic Agents Value Chain Analysis
  2. 9.1.1 Hemostatic Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemostatic Agents Production Mode & Process
  6. 9.2 Hemostatic Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemostatic Agents Distributors
  9. 9.2.3 Hemostatic Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst